Press releases
- Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
- Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
- Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
- Accuray to Participate in the Jefferies Global Healthcare Conference 2024
- Accuray Reports Fiscal 2024 Third Quarter Financial Results
More ▼
Key statistics
On Thursday, Accuray Inc (0H8I:LSE) closed at 1.91, 27.03% above the 52 week low of 1.50 set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 1.91 |
Average volume | 429.88 |
---|---|
Shares outstanding | 99.24m |
Free float | 95.83m |
P/E (TTM) | -- |
Market cap | 192.53m USD |
EPS (TTM) | -0.2197 USD |
Data delayed at least 20 minutes, as of Jul 25 2024 15:12 BST.
More ▼